SCHEMBL5202937

SCHEMBL5202937

Nc1ncc(Cc2ccc(C(F)(F)F)cc2Cl)c(N2CCC(=O)CC2)n1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TRAP1 Q12931 2/20 0.42
DHFR P00374 3/20 0.41
SMN1; SMN2 Q16637 6/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
LMNA P02545 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 2/20 0.38
TP53 P04637 1/20 0.38
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
POLB P06746 1/20 0.37
CYP2C19 P33261 1/20 0.37
RECQL P46063 1/20 0.37
DAO P14920 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5206429 0.88 TRAP1 (0.39) TRAP1DHFRSMN1; SMN2LMNAALDH1A1
SCHEMBL5205412 0.86 SMN1; SMN2 (0.43) DHFRSMN1; SMN2NPC1LMNAALDH1A1
SCHEMBL5205010 0.84 TRAP1 (0.38) TRAP1DHFR
SCHEMBL5202725 0.84 HSP90AA1 (0.38) TRAP1DHFRPIK3CAPOLB
SCHEMBL5206883 0.84 DHFR (0.43) TRAP1DHFRPIK3CAPIK3CB
SCHEMBL7163515 0.83 RPS6KB1 (0.44) SMN1; SMN2NPC1RAB9ALMNAALDH1A1
SCHEMBL5209661 0.82 DHFR (0.42) DHFRPIK3CA
SCHEMBL5202458 0.82 DHFR (0.48) DHFRCYP2C19
SCHEMBL5204607 0.76 DHFR (0.40) DHFR
SCHEMBL5203846 0.74 SMN1; SMN2 (0.40) DHFRSMN1; SMN2NPC1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP claimed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US claimed
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP disclosed
US-6916820-B1 Neurotrophic substituted pyrimidines KRENITSKY PHARMACEUTICALS, INC. (US) 2005-07-12 US disclosed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed